431 related articles for article (PubMed ID: 11724349)
61. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN
Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723
[TBL] [Abstract][Full Text] [Related]
62. Detection of p53 gene mutations: analysis by single-strand conformation polymorphism and Cleavase fragment length polymorphism.
O'Connell CD; Atha DH; Oldenburg MC; Tian J; Siebert M; Handrow R; Grooms K; Heisler L; de Arruda M
Electrophoresis; 1999 Jun; 20(6):1211-23. PubMed ID: 10380761
[TBL] [Abstract][Full Text] [Related]
63. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
64. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
[TBL] [Abstract][Full Text] [Related]
65. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system.
Ohgaki H; Eibl RH; Schwab M; Reichel MB; Mariani L; Gehring M; Petersen I; Höll T; Wiestler OD; Kleihues P
Mol Carcinog; 1993; 8(2):74-80. PubMed ID: 8397797
[TBL] [Abstract][Full Text] [Related]
66. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
Gao ZQ; Gao Z; Zhang X
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):88-91. PubMed ID: 9812619
[TBL] [Abstract][Full Text] [Related]
67. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
Lee CH; Kweon OK
J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
[TBL] [Abstract][Full Text] [Related]
68. Rare mutations of the DMBT1 gene in human astrocytic gliomas.
Mueller W; Mollenhauer J; Stockhammer F; Poustka A; von Deimling A
Oncogene; 2002 Aug; 21(38):5956-9. PubMed ID: 12185598
[TBL] [Abstract][Full Text] [Related]
69. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
[TBL] [Abstract][Full Text] [Related]
70. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
71. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
Zhang LN; Zha XL; Yu Q; He JY
Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
[TBL] [Abstract][Full Text] [Related]
72. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
[TBL] [Abstract][Full Text] [Related]
73. Analyses of p53 gene mutations in primary human bladder cancer.
Miyamoto H; Kubota Y; Shuin T; Torigoe S; Hosaka M; Iwasaki Y; Danenberg K; Danenberg PV
Oncol Res; 1993; 5(6-7):245-9. PubMed ID: 8123944
[TBL] [Abstract][Full Text] [Related]
74. [The research on p53 gene mutation in lung cancer tissue of silicotic patients by PCR-SSCR].
Zhou P; Liu B; Miao Q; Wang H
Wei Sheng Yan Jiu; 1997 Sep; 26(5):293-5, 298. PubMed ID: 10325639
[TBL] [Abstract][Full Text] [Related]
75. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
[TBL] [Abstract][Full Text] [Related]
76. P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.
Van Leeuwen IS; Hellmèn E; Cornelisse CJ; Van den Burgh B; Rutteman GR
Anticancer Res; 1996; 16(6B):3737-44. PubMed ID: 9042250
[TBL] [Abstract][Full Text] [Related]
77. Timing of p53 mutations during astrocytoma tumorigenesis.
del Arco A; García J; Arribas C; Barrio R; Blázquez MG; Izquierdo JM; Izquierdo M
Hum Mol Genet; 1993 Oct; 2(10):1687-90. PubMed ID: 8268922
[TBL] [Abstract][Full Text] [Related]
78. Mutation spectrum of p53 gene in highly malignant human osteosarcomas.
Radig K; Schneider-Stock R; Oda Y; Neumann W; Mittler U; Roessner A
Gen Diagn Pathol; 1996 Jun; 142(1):25-32. PubMed ID: 8793483
[TBL] [Abstract][Full Text] [Related]
79. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R
Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
[TBL] [Abstract][Full Text] [Related]
80. [Greater sensitivity of the PCR-SSCP technique compared with immunohistochemistry for the detection of exon 5 and 6 mutations of gene 53 in breast cancer].
Dueñas González A; Cruz Hernández JJ; Abad Hernández MM; Ramos M; González Sarmiento R
Med Clin (Barc); 1996 May; 106(19):721-4. PubMed ID: 8801382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
